The Immunology of Psoriasis-Current Concepts in Pathogenesis
Open accessThe DOI matches its Crossref record; 308 of the 308 references it cites were found in a registry or an index.
Abstract
Psoriasis is one of the most common inflammatory skin diseases with a chronic, relapsing-remitting course. The last decades of intense research uncovered a pathological network of interactions between immune cells and other types of cells in the pathogenesis of psoriasis. Emerging evidence indicates that dendritic cells, T H 17 cells, and keratinocytes constitute a pathogenic triad in psoriasis. Dendritic cells produce TNF-α and IL-23 to promote T cell differentiation toward T H 17 cells that produce key psoriatic cytokines IL-17, IFN-γ, and IL-22. Their activity results in skin inflammation and activation and hyperproliferation of keratinocytes. In addition, other cells and signaling pathways are implicated in the pathogenesis of psoriasis, including T H 9 cells, T H 22 cells, CD8 + cytotoxic cells, neutrophils, γδ T cells, and cytokines and chemokines secreted by them. New insights from high-throughput analysis of lesional skin identified novel signaling pathways and cell populations involved in the pathogenesis. These studies not only expanded our knowledge about the mechanisms of immune response and the pathogenesis of psoriasis but also resulted in a revolution in the clinical management of patients with psoriasis. Thus, understanding the mechanisms of immune response in psoriatic inflammation is crucial for further studies, the development of novel therapeutic strategies, and the clinical management of psoriasis patients. The aim of the review was to comprehensively present the dysregulation of immune response in psoriasis with an emphasis on recent findings. Here, we described the role of immune cells, including T cells, B cells, dendritic cells, neutrophils, monocytes, mast cells, and innate lymphoid cells (ILCs), as well as non-immune cells, including keratinocytes, fibroblasts, endothelial cells, and platelets in the initiation, development, and progression of psoriasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The most frequent and important findings are represented by the psoriasiform pattern associated with confluent parakeratosis and chronic dermal inflammation.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dilated and tortuous capillaries are frequently present in the papillary dermis and correspond clinically to the Auspitz phenomenon [20].”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The disease is characterized by hyperproliferation of the epidermis, with a high epidermal turnover rate and scale formation.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Neutrophilic collections represent important diagnostic clues.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fully developed plaques typically demonstrate regular acanthosis with elongated and relatively uniform rete ridges, thinning of the suprapapillary plates, confluent parakeratosis, and reduction or absence of the granular layer.”
From The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy (2026) · cites this paper as [20]
Experimental — accuracy not yet measured
13 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265 · cited 2×
“However, IL-17 is also implicated in a variety of T H 17-mediated inflammatory autoimmune diseases [113, 114].”
BackgroundIL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review
Armstrong, A. W., & Read, C. (2020) · JAMA · doi:10.1001/jama.2020.4006 · Cited by 2,335
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330 · cited 2×
“It was demonstrated that IL-17 and IL-22 can be co-expressed by T H 17 cells and synergize in the induction of the expression of AMPs by KCs in vitro [208].”
BackgroundPsoriasis Pathogenesis and Treatment
Rendon, A., & Schäkel, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061475 · Cited by 2,064
Development, cytokine profile and function of human interleukin 17-producing helper T cells
Wilson, N. J., Boniface, K., Chan, J. R., McKenzie, B. S., Blumenschein, W. M., Mattson, J. D., Basham, B., Smith, K., Chen, T., Morel, F., et al. (2007) · Nature Immunology · doi:10.1038/ni1497 · Cited by 2,035
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., et al. (2007) · Nature · doi:10.1038/nature06116 · Cited by 1,910 · cited 3×
“Complexes consisting of DNA or RNA and LL37 are abundant in lesional skin [19, 106].”
BackgroundInterleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862 · cited 1×
“IL-22 produced by T H 22 cells mediates acanthosis and immune cell infiltration induced by IL-23 [69].”
BackgroundAggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847 · cited 3×
“T H 17 cells are activated by factors that are upregulated in the psoriatic milieu, including IL-23, as well as IL-21 in an autocrine manner [68, 74].”
Background
Cited by
Feng, C., Wen, Y., Mei, Z., & Luo, X. (2025) · Journal of Environmental Management · doi:10.1016/j.jenvman.2025.125708 · Cited by 69
Systemic Psoriasis: From Molecular Mechanisms to Global Management Strategies
Prema, S. S., & Shanmugamprema, D. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09089-4 · Cited by 43
Li, B., Li, X., Li, S., Chen, C., Xiao, T., & Xu, Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140156 · Cited by 35
Zhu, Y. J., Zhou, Y. Q., Ma, X.-N., Duan, Z., Xu, H. H., Li, Y., Kong, Y., Yang, L., & Xin, X. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17030283 · Cited by 32
“These inflammatory immune cells communicate with each other through various inflammatory factors, such as TNF-α , IFN-γ , IL-17, and IL-22 [19].”
Interventions in cytokine signaling: novel horizons for psoriasis treatment
Li, L., Liu, J., Lu, J., Wu, J., Zhang, X., Ma, T., Wu, X., Zhu, Q., Chen, Z., & Tai, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1573905 · Cited by 39
“While neutrophils do not directly express IL-17A, they can accumulate and release it via extracellular traps (103).”
Machoń, N. J., Zdanowska, N., Klimek-Trojan, P., & Owczarczyk-Saczonek, A. B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020792 · Cited by 26
“Among the comorbidities associated with psoriasis, it is important to note those also associated with systemic inflammation, such as psoriatic arthritis, cardiovascular disease, metabolic syndrome, obesity, inflammatory bowel disease, and psychiatric disorders [1].”
Liu, S., Song, S., Zhang, Y., Yan, L., Chen, Y., Li, W., Jalil, B., Wu, C. F., Fu, Y., Chen, X., et al. (2025) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2025.123777 · Cited by 26
Klimitz, F. J., Shen, Y., Repetto, F., Brown, S., Knoedler, L., Ko, C. J., Hussein, N. S. A., Crisler, W. J., Adams, T. S., Kaminski, N., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1694066 · Cited by 31
“This Th17-driven mechanism aligns closely with fi ndings by Sieminska et al., who delineated the TNF-a /IL-23/IL-17 axis as central in psoriasis in fl ammation (120).”
Dimeji, I. Y., Abass, K. S., Audu, N. M., & Adekola, S. A. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177615 · Cited by 31
Cutaneous Adverse Events Following Nemolizumab Administration: A Review
Mima, Y., Yamamoto, M., & Iozumi, K. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14093026 · Cited by 23
“Key cytokines involved include IL-17, IL-21, IL-22, interferon-γ , tumor necrosis factor-α , IL-6, IL-20, and IL-23, which are produced by T cells, dendritic cells, and keratinocytes [68].”
InfluentialLok, K.-H., Loo, H. L., & Chuah, L. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01940-7 · Cited by 29
“Presenting as a chronic papulosquamous skin disease, the pathogenesis of psoriasis has been determined to primarily involve inflammation of the skin modulated by numerous immunological pathways with underlying genetic pre-dispositions [120, 121].”
Alterations of gut microbiota for the onset and treatment of psoriasis: A systematic review
Xue, M., Deng, Q., Deng, L., Xun, T., Huang, T., Zhao, J., Wei, S., Zhao, C., Chen, X., Zhou, Y., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177521 · Cited by 30
Simancas‐Racines, D., Román-Galeano, N. M., Verde, L., Annunziata, G., Marchetti, M., Matos, A., Campuzano-Donoso, M., Reytor-González, C., Muscogiuri, G., Barrea, L., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072895 · Cited by 24
“These cytokines orchestrate the recruitment and activation of immune cells, notably T-helper 17 (Th17) cells and dendritic cells, creating a self-perpetuating inflammatory loop [9].”
Advances in Psoriasis Research: Decoding Immune Circuits and Developing Novel Therapies
Wang, L., Liu, R., Tang, Y.-L., Ma, Y.-F., Wang, G., Ruan, Q., & Zheng, S. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189233 · Cited by 33
“It was found that psoriatic skin lesions are enriched with CD4 + T cells [121].”
He, H., Jiang, Y., Qiu, J., Shen, F., Qian, D., & Meng, L. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2586216 · Cited by 27
“The potential risk of endocrine disruption further limits their use in this population [84–86].”
Unveiling multifaceted roles of myeloid innate immune cells in the pathogenesis of psoriasis
Park, S.-H., Jang, J., Kim, H. J., & Jung, Y. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101306 · Cited by 25
Mustafa, A. M., Atwa, A. M., Elgindy, A. M., Alkabbani, M. A., Ibrahim, K. M., Esmail, M. M., El‐Shiekh, R. A., Mohamed, E. M., & Kamel, K. M. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01851-6 · Cited by 26
The cytokine–skin barrier axis in health and disease
Souto-Silva, M. V., Bispo, E. C. I., de Oliveira, N. N., Pogue, R. E., Zonari, A. A. C., Saldanha‐Araújo, F., & Carvalho, J. L. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.12.009 · Cited by 22
The Role of Fibroblasts in Chronic Inflammatory and Proliferative Skin Diseases
Zang, R., Xu, C., Fan, Z., Wang, Q., Guo, Z., Liu, L., Cui, B., Huang, Y., & Yang, J. (2025) · Experimental Dermatology · doi:10.1111/exd.70066 · Cited by 17
Jo, H.-G., Seo, J., Jang, B., Kim, Y., Kim, H., Baek, E., Park, S.-Y., & Lee, D. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103836 · Cited by 19
The M2 Macrophages Importance Role in Psoriasis
Alshihmani, A. H. H., Mahmoudi, M., Kheder, R. K., Fadaee, A., & Esmaeili, S. (2025) · Immunity, Inflammation and Disease · doi:10.1002/iid3.70211 · Cited by 16
Sutar, A. D., & Shukla, R. (2025) · RSC Pharmaceutics · doi:10.1039/d5pm00173k · Cited by 15
Xiong, H., & Yu, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1556487 · Cited by 14
“The distinct leukocyte distribution in the blood of psoriasis patients, characterized by an increase in neutrophil counts (4), is a notable fi nding that supports this understanding.”
Dashti, M., Mohammadi, M., Dehnavi, S., & Sadeghi, M. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04375-6 · Cited by 19
Tang, L., Bi, G., Lin, K., Chen, Y., Xian, H., Li, Y., Xie, H., Zheng, G., Wang, P., Chen, Y., et al. (2025) · Psoriasis Targets and Therapy · doi:10.2147/ptt.s535900 · Cited by 17
“20 Once stimulated with psoriasis-specific autoantigens, such as cathelicidin LL37, 21 the plasmacytoid dendritic cells (pDCs) activate and release a series of cytokines like interleukin-23 (IL-23) and tumor necrosis factor-alpha (TNF-α), thereby triggering the helper T (Th) cells differentiation…”
Fratton, Z., Giovannini, I., Zabotti, A., & Errichetti, E. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13226880 · Cited by 13
“While the immunopathogenesis of skin psoriasis has been extensively studied [30], less is known about the immunobiological events at the base of nail psoriasis development, mainly due to an intrinsic difficulty in collecting fresh samples of psoriatic nail unit tissue for immunohistological…”
Keshari, R., Bagale, R., Rath, S., De, A., Banerjee, R., Sen, S., & Srivastava, R. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125325 · Cited by 13
Moawad, F., Ruel, Y., Pouliot, R., & Brambilla, D. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202504294 · Cited by 13
Spatial Imbalance of Innate-like T-Cell Niches Underlies Clinical Trajectories in Psoriasis
Bonilha, C. S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020715 · Cited by 13
“Within this environment, innate-like T cells (iLTCs), including γδ T cells and mucosal-associated invariant T cells (MAIT) cells, contribute to local immune responses as rapid sentinel populations positioned at the barrier surface [2,3].”
Tarek, M. T., El-Gogary, R. I., & Kamel, A. O. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125385 · Cited by 15
NLRP3-inflammasome Related Genes as Emerging Biomarkers and Therapeutic Targets in Psoriasis
Shi, A., Shu, Y., Hu, K., Sudesh, S. M., & Tu, Y. (2025) · Inflammation · doi:10.1007/s10753-025-02271-y · Cited by 15
Clinical features, treatment, and outcomes of anti-PD-L1 induced psoriasis
Xiao, J., Xia, Z., Wu, Z., & Fang, M. (2025) · Investigational New Drugs · doi:10.1007/s10637-025-01554-3 · Cited by 12
“Additionally, as a chronic inflammatory disease, the detection of inflammatory-related cells such as lymphocytes, neutrophils and eosinophils can also aid in the diagnosis of psoriasis [25].”
The Perivascular Fat Attenuation Index: Bridging Inflammation and Cardiovascular Disease Risk
Němečková, E., Krása, K., & Malý, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14134753 · Cited by 11
“The identified genes are involved in antigen presentation (HLA-Cw6), cytokine signaling (IL12B, IL23R), and interferon and NF-κ B signaling [61].”
Review of Excessive Cytosolic DNA and Its Role in AIM2 and cGAS-STING Mediated Psoriasis Development
Xu, T., Zhong, X., Luo, N., Ma, W., & Hao, P. (2024) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s476785 · Cited by 15
Causal relationships between allergic and autoimmune diseases with chronic rhinosinusitis
Tu, J., Zhang, Z., Jiang, F., Wen, J., Luo, Q., & Ye, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-77131-0 · Cited by 14
“These cytokines disrupt the normal skin cell life cycle, resulting in rapid growth and the formation of the characteristic plaques 47 .”
BackgroundUnraveling the causal associations between systemic cytokines and six inflammatory skin diseases
Liu, W., Zhang, X., & Chen, X. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156810 · Cited by 13
Targeting fibroblast TNF receptor 1 attenuates type 17 skin inflammation
Cavagnero, K. J., Li, F., Aguilera, C., Jo, H., Palomo-Irigoyen, M., Mares, A. R., Chan, H., & Gallo, R. L. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116111 · Cited by 12
Giulio, S. D., Falcidia, C., Foggi, G., Bianco, M., Gargiulo, L., Valenti, M., Costanzo, A., Narcisi, A., & Ibba, L. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14186371 · Cited by 10
“Among the cytokine networks implicated, the IL-23/IL-17 axis is particularly critical [5].”
Advances in the Drug Delivery Systems for Psoriasis Topical Therapy
Liu, Y., Chang, R., Deng, H., Liang, F., Xu, X. M., & Luo, Y. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s529899 · Cited by 11
“6,7 10 Thus, the clinical treatment of PSO is difficult and can recur easily, which seriously affects the quality of life of patients.”
Wang, H., Huang, S., Ren, J., Peng, L., Chen, L.-R., Qi, L.-Y., Zhu, K.-H., Feng, C., Zhou, R., Gu, Y., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.04.034 · Cited by 12
“Mono-cytes and its derived macrophages, neutrophils and dendritic cells amplify inflammation in psoriasis by secreting cytokines and activating adaptive immune [51].”
Darouni, L., Razavi, F. T., Yazdanpanah, E., Orooji, N., Shadab, A., Emami, A., Molavi, H., & Haghmorad, D. (2025) · Inflammation Research · doi:10.1007/s00011-025-02084-7 · Cited by 11
“The pathophysiology of psoriasis involves a complex interplay between innate and adaptive immune responses [109].”
Immune triad microenvironments define coordinated activation architecture in psoriatic disease
Bonilha, C. S. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116337 · Cited by 9
Histone Modifications and DNA Methylation in Psoriasis: A Cellular Perspective
Pan, J., Chen, S., Chen, X., Song, Y., & Cheng, H. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-024-09014-1 · Cited by 11
Hard-to-Treat Areas in Psoriasis: An Underevaluated Part of the Disease
Lupulescu, A.-M., Savu, A.-P., Bucur, Ș., Serban, E. D., Popescu, S., & Constantin, M. M. (2025) · Life · doi:10.3390/life15030425 · Cited by 7
“Other cells involved in this complex mechanism of psoriasis’ pathogenesis are represented by neutrophils, cytotoxic cells, Th9, Th22, Th1 with all the cytokines and chemokines they secrete (Figure 1) [7–9].”
Song, Q., Xu, P., Xiao, Q., Zhang, C., & Mao, Y. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13534 · Cited by 8
“These Th1 cells then produce notable amounts of IFN‑ γ and TNF‑ α , amplifying the inflammatory response and creating a feedback loop that exacerbates the condition (63).”
InfluentialTapinarof Nanogels as a Promising Therapeutic Approach
Balogh, B., Pető, Á., Fehér, P. S., Ujhelyi, Z., & Bácskay, I. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17060731 · Cited by 9
“It can lead to the erosion of cartilage tissue in joints and cause irreversible joint damage in the long term [12,18,19,21].”
InfluentialNew Therapies in the Biological Treatment of Psoriasis: A Review
Ożóg, M. K., Derkacz, A., Klimczak, D., Winkler, S., & Wojciuch, L. (2025) · Allergies · doi:10.3390/allergies5020019 · Cited by 7
Dongsar, T. S., Dongsar, T. T., Alsayari, A., Wahab, S., Gupta, G., & Kesharwani, P. (2025) · AAPS PharmSciTech · doi:10.1208/s12249-025-03179-4 · Cited by 8
“Despite the substantial progressions in understanding the pathophysiology of psoriasis a definitive cure still remains elusive [8, 13].”
Li, Y., Ye, L., Cui, Y.-Z., Xu, F., Chen, X., Zhang, F.-F., Lü, Y., Zheng, Y.-X., & Man, X. (2025) · JCI Insight · doi:10.1172/jci.insight.192507 · Cited by 9
“After incubation, the cells were fixed and permeabilized (Thermo Fisher Scientific, #00552300), followed by staining for TNF-α and IFN-γ .”
InfluentialBotulinum Toxin Treatment of Psoriasis—A Comprehensive Review
Ghaseminejad‐Bandpey, A., Etemadmoghadam, S., & Jabbari, B. (2024) · Toxins · doi:10.3390/toxins16100449 · Cited by 7
Formulation and Evaluation of Different Nanogels of Tapinarof for Treatment of Psoriasis
Balogh, B., Pető, Á., Haimhoffer, Á., Sinka, D., Kósa, D., Fehér, P. S., Ujhelyi, Z., Argenziano, M., Cavalli, R., & Bácskay, I. (2024) · Gels · doi:10.3390/gels10110675 · Cited by 9
“The molecule is able to reduce oxidative stress via increased antioxidant response through the Nrf2 pathway [2,3,5,7,8,11–13 The main problem with transdermal drug delivery is the barrier properties of the stratum corneum, which is considered one of the most impermeable epithelial layers of the…”
Branisteanu, D. E., Ciobanu, R. P., Brănişteanu, D. C., Colac-Boțoc, C., Huțanu, A. E., Munteanu, C.-A., Stamate, R., Brănișteanu, G., Branisteanu, C., Toader, M. P., et al. (2025) · Diagnostics · doi:10.3390/diagnostics15101231 · Cited by 8
Psoriasis unveiled: The cellular ballet, molecular symphony, and genetic puzzle
Sharma, A., Dhiman, S., Singh, T. G., Bhatia, R., & Awasthi, A. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115021 · Cited by 9
Husain, A., Kushwaha, P., Kapoor, A., & Singh, P. (2025) · AAPS PharmSciTech · doi:10.1208/s12249-025-03188-3 · Cited by 6
“Epidemiological data indicate substantial geographic variation in prevalence, ranging from 0.9% in the United States to 8.5% in Norway [3].”
InfluentialGreater psoriatic disease progression in male BALB/c mice: implications for preclinical modeling
Singaravel, V., & Moovendhan, M. (2025) · Discover Applied Sciences · doi:10.1007/s42452-025-08013-x · Cited by 7
“This functional dichotomy is mirrored in psoriasis patients, where diminished IL-10 expression has been consistently observed in lesional skin, underscoring its role in moderating cutaneous immune responses [30–32].”
Integrating clinical challenges and nanotechnological based approaches for psoriasis therapy
Silvestrini, A. V. P., da Silva, U. J., Morais, M. F., Depieri, L. V., & Bentley, M. V. L. B. (2025) · Biomaterials Advances · doi:10.1016/j.bioadv.2025.214625 · Cited by 6
Unveiling the IL-17 axis: an immunometabolic bridge between psoriasis and metabolic syndrome
Gisondi, P., Fratton, Z., da Rosa, R. V., Bellini, V., & Carugno, A. (2026) · Journal of Dermatological Treatment · doi:10.1080/09546634.2026.2673285 · Cited by 8
Jo, H.-G., Kim, H., Baek, E., Seo, J., & Lee, D. (2024) · Nutrients · doi:10.3390/nu16162690 · Cited by 6
Emerging Contaminants: An Important But Ignored Risk Factor for Psoriasis
Huang, L., Zhou, Y. Y., Xiao, H., Li, Y., Zhou, Z., Xiao, Z., Tong, Y., Hu, K., Kuang, Y., Shen, M., et al. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09043-4 · Cited by 7
“Psoriasis is a chronic skin disease which cannot be cured [1, 2].”
Revolutionizing psoriasis care: Microneedle innovations in treatment and diagnosis
Hu, W., Pan, H., Jiang, Z., Jian, J., Zhou, C., Gong, M., Lai, Z., Lu, C. T., Quan, G., Wu, C., et al. (2025) · Nano Research · doi:10.26599/nr.2025.94907639 · Cited by 5
Yu, Y., Lv, X., Chen, Z., Li, X., Chen, L., Chen, Y., Gu, W., Zhou, X., Li, J., & Shi, D. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01266 · Cited by 6
Chen, Q., Wang, W., He, X., Wang, C., Guo, H., & Ou, C. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218034 · Cited by 7
Abou‐Bakr, A., Hassanein, F. E. A., nagi, N., Ibrahim, M., & Mekhemar, M. K. (2025) · Cells · doi:10.3390/cells14181421 · Cited by 6
“Self-ligand-induced TLR4 activation in psoriasis promotes keratinocyte proliferation and the chronic inflammatory loop [27].”
Szepietowski, J. C., Reich, A., Feldman, S. R., Pulka, G., Mekokishvili, L., TSISKARISHVILI, N. I., Svarca, I., Põder, A., Singh, G., Deodhar, S. S., et al. (2025) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2025.2576506 · Cited by 5
“Many of the susceptibility loci are linked to the nuclear factor-kappa B pathway, interleukin (IL)-12B, IL-17, and IL-23 R [2,3].”
Mechanobiology of neutrophil inflammasome signaling in psoriasis
Matsushima, Y., Hwang, S. T., & Simon, S. I. (2025) · Current Opinion in Immunology · doi:10.1016/j.coi.2025.102680 · Cited by 6
Zhou, H., Lu, J., Yin, B., Meng, Y., Zhu, C., Wu, X., Liu, J., Zhu, Q., Tai, Z., & Chen, Z. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202504232 · Cited by 5
“Psoriatic inflammation is primarily driven by Th1/Th17 responses and inflammatory cells via cytokines such as IL-17, IFN-γ , and TNF-α , which sustain a local inflammatory circuit [36, 37].”
Lu, Y., Xu, F., Qi, F., & Pan, Y. (2026) · Biomolecules · doi:10.3390/biom16030414 · Cited by 5
“Similarly, mast cells contain IL-17 in their cytoplasmic granules, releasing it through degranulation to create an instant pro-inflammatory cytokine response during tissue damage [44].”
Immunoregulation by DC and T cells in psoriasis with probable immunotherapeutic approaches
Kundu, S., Paul, R., & Chakraborty, K. (2026) · International Reviews of Immunology · doi:10.1080/08830185.2026.2650139 · Cited by 6
“…the core inflammatory driver in psoriasis, with dendritic cells and macrophages producing IL-23 to sustain pathogenic Th17 cells and other IL-17–producing lymphocytes, leading to elevated IL-17A, IL-17F, and IL-22 that stimulate keratinocyte proliferation and inflammatory mediator release [5,29].”
InfluentialOjha, M., Manocha, N., Madaan, A., Gupta, N., Khurana, S., Chaudhary, A., Kumar, V., Karthikeyan, G., & Toor, D. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118596 · Cited by 5
Zhao, K., Xiao, S., Zhao, Y. W., & Tu, C. (2025) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2025.2520422 · Cited by 5
“Particularly, the IL-23/Th17 axis has been recognized as a central immunopathogenic pathway in the development and maintenance of psoriatic inflammation, informing the rationale for recent targeted therapeutic strategies [4–6].”
Shared Pathophysiology of Inflammatory Bowel Disease and Psoriasis: Unraveling the Connection
Jauregui, W., Abarca, Y. A., Ahmadi, Y., Menon, V. B., Zumárraga, D. A., Gomez, M. C. R., Basri, A., Madala, R. S., Girgis, P. A., & Nazir, Z. (2024) · Cureus · doi:10.7759/cureus.68569 · Cited by 13
“Psoriasis is characterized by a chronic, relapsing-remitting course [35].”
BackgroundTang, J., Zhao, S., Su, Y., Shi, H., Li, X., Zhang, X., Wang, J., Jin, X., & He, Y. (2025) · Experimental Dermatology · doi:10.1111/exd.70128 · Cited by 7
“IL-23, a pro-inflammatory cytokine, is primarily secreted by cDCs in psoriasis and is essential for Th17 cell activation and cytokine production [35–37].”
Maldonado-García, J. L., Fragozo, A., & Pavón, L. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i35.6782 · Cited by 6
Qu, B., Li, G., Zhao, N., Li, R., Ma, H., Zhu, H., Li, P., & Zhao, J. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156379 · Cited by 7
Lin, C., Chen, H., Alalaiwe, A. S., Hsiao, Y.-T., Jhong, C., Chang, S., & Fang, J. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00352 · Cited by 9
Identification of STAT3 and BIRC5 as anoikis-related biomarkers in psoriasis
Bai, W., Wang, K., Wu, S., Zhou, X., Liu, L., Liu, M., & Chen, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-13992-3 · Cited by 4
“These two cells are closely related to the formation and development of psoriasis 41 .”
The Role of Visfatin/NAMPT in the Pathogenesis of Psoriasis
Matwiejuk, M., Kulczyńska‐Przybik, A., Łukaszuk, B., Myśliwiec, H., Myśliwiec, P., Chabowski, A., Mroczko, B., & Flisiak, I. (2025) · Metabolites · doi:10.3390/metabo15090590 · Cited by 4
“Psoriasis is a common chronic inflammatory and autoimmune skin disease characterised by alternating periods of exacerbation and remission [1].”
Wang, W., Zhang, J., Jiang, S.-L., Rao, Z.-M., Liu, H., Wang, L., Cai, C.-L., Yu, C.-H., Yu, C.-H., & Wang, W. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120607 · Cited by 5
Medjedovic, L., Vižlin, A., Björkman, Y. A., Albertsson, A.-M., Raghavan, S., Gillstedt, M., & Osmančević, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27010458 · Cited by 4
“IL-17A, mainly produced by Th17 cells, acts on keratinocytes, promoting their hyperproliferation and stimulating them to secrete chemokines that attract additional immune cells [5].”
InfluentialOjha, V., Tembhre, M. K., & Gupta, V. (2026) · Antioxidants · doi:10.3390/antiox15010071 · Cited by 5
“It is considered to be major health burden globally, as it encompasses not only dermatology (skin involvement) and rheumatology (joint involvement) but is associated with various metabolic and cardiovascular diseases [43–47].”
Autoimmune skin disease pathogenesis: a chronological immune cascade and multi-hit model
Chen, J., Yin, H., Li, S., & Li, C. (2026) · Immunity & Inflammation · doi:10.1007/s44466-025-00017-x · Cited by 5
Shen, Y.-H., Ho, P.-Y., & Huang, Y. (2026) · Experimental Dermatology · doi:10.1111/exd.70214 · Cited by 6
“Activated T cells preferentially accumulate and proliferate within the epidermis in patients with psoriasis [93, 94].”
Role of transient receptor potential channels on pathogenesis and treatment of psoriasis
da Silva, A. M., Nassini, R., Logu, F. D., & Ferreira, J. (2026) · Inflammopharmacology · doi:10.1007/s10787-025-02095-0 · Cited by 5
“…mole - cules are involved, including macrophages, neutrophils, and gamma-delta T (γδ T) cells, as well as their related cyto - kines (for a comprehensive review of signaling pathways involving extracellular cytokines and intracellular transmis - sion, see Guo et al. 2023; Sieminska et al. 2024 ).”
Fatty acid–related immune network in psoriasis: metabolic regulation of innate and adaptive immunity
Wen, P., Zhuo, X., & Xue, S. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1731683 · Cited by 4
“Psoriasis pathogenesis is governed by the TNF-α /IL-23/IL-17 axis and dysregulated keratinocyte differentiation (Takeshita et al., 2017; Sieminska et al., 2024; Menter et al., 2021; Chiricozzi et al., 2011).”
Jaswal, A., Kumar, A., Patel, P., & Kurmi, B. D. (2026) · Immunological Investigations · doi:10.1080/08820139.2026.2645963 · Cited by 5
“It is consideredas systemic disease related to metabolic syndrome, obesity, and increased cardiovascular risk (Campanati et al., 2021; Sieminska et al., 2024).”
Chiang, Y.-L., Li, T.-H., Fang, Y.-W., Liu, Y.-F., Wu, J., & Tsai, M. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1801203 · Cited by 5
Xu, R., Wang, P., Cao, C., Cai, M., Dai, X., Peng, Y., Yue, Y., Sun, Y., Gao, H., Song, P., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101822 · Cited by 4
“This multifaceted condition results from a complex interplay of genetic, immunological, and environmental factors [2 – 4], yet its precise etiology remains largely elusive.”
Integrated analysis of exosome-related genes and their role in psoriasis pathogenesis
Wang, Z., & Luo, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1492012 · Cited by 5
Sora, A., Hangan, T., Chirila, S. I., Gurgas, L., Botnarciuc, M., Daba, L. C., Cretu, A. M., Burlacu, I., Zamfirescu, M., Petcu, A., et al. (2025) · Medicina · doi:10.3390/medicina61071180 · Cited by 5
“…specificity and mechanistic insights but require invasive sampling and are less practical for routine monitoring, while skin autofluorescence provides a non-invasive visual assessment of epidermal changes, though it remains technically limited and less validated across clinical settings [25,26].”
Transdermal hydrogen therapy for psoriasis using cavity-embedded double-conical microneedles
Zhu, D., Lim, R. Y. D., Poh, Y. L., Li, D., Raghavan, S., & Chen, P. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114313 · Cited by 4
Simultaneous targeting of multiple etiological using a nanosized strategy for psoriasis management
Jiang, X., Wang, M., Zhang, L., Huang, Z., Mao, P., Zhao, Y., Tao, Z., Han, Y., Cai, L., Zhang, K., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102593 · Cited by 4
“Psoriasis is widely recognized as an immune-mediated inflammatory disease characterized by systemic immune dysregulation [86].”
Mapping the psoriasis research landscape: A comprehensive bibliometric analysis from 2012-2023
Garg, S., Chawla, M., Dixit, M., Sharma, A., Singh, M., Singh, V., Ahmad, S. F., & Attia, S. M. (2024) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320241290341 · Cited by 4
Novel ribosome biogenesis-related biomarkers and therapeutic targets identified in psoriasis
Liu, J., Luo, N., Ma, W., Qiao, Z., Zhong, X., Cheng, Z., Hao, P., & Lv, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-03833-8 · Cited by 5
Zhang, X., Wei, K., Song, H., Chen, X., Yang, J., Zhao, J., Jiang, Y., & He, X. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1544197 · Cited by 5
Zeldin, J., Jordan, J., Thota, P., Vuong, R., Jojo, C., & Myles, I. A. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1585525 · Cited by 3
“…particularly T-helper (Th-)17 cells, are central to the disease process, with significantly higher numbers found in active lesions compared to healthy skin, producing excessive amounts of cytokines such as interleukin (IL-)17A, IL-22, and IFN-γ , which drive keratinocyte proliferation (9, 10).”
Celiac Disease and Skin Diseases: A Bidirectional Mendelian Randomization Study
Ge, C., Wang, Y., Zhao, X., Hao, J., Zhang, J., Lu, M., Li, C., Feng, J., & Zhang, Q. (2025) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s533378 · Cited by 3
“54 On the other hand, IL-17 promotes the formation of tight junctions in the intestinal epithelium and increases transepithelial electrical resistance, while IL-22 induces mucin secretion by goblet cells and upregulates tight junction protein expression.”
Zhang, W., Li, F., Wang, Y., Fan, M., Zhao, Y., Guan, Y., Zhou, Y., Lu, S., Holmdahl, R., Meng, L., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08628-1 · Cited by 3
Advances of bispecific antibodies using/application in dermatology: a review
Zhang, T., Yang, J., Liew, P. X., Zhang, Y., & Zhao, Z. (2025) · Frontiers in Allergy · doi:10.3389/falgy.2025.1668931 · Cited by 3
Effects of the ketogenic diet on skin—potential benefits and risks
Chylińska, N., & Maciejczyk, M. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1686056 · Cited by 4
“In turn, T cells produce inflammatory cytokines, such as IL-17 and IL-23, which exacerbate skin inflammation (206, 209).”
Bioinformatics analyses of comorbid mechanisms between psoriasis and type 2 diabetes mellitus
Wang, Z., Mu, J., Zhang, Y., Huang, H., Qin, C., Hu, G., Wang, J., Zhang, P., Cui, H., Huang, W., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-20762-8 · Cited by 3
Metadata
- Authors
- Sieminska, I., Pieniawska, M., & Grzywa, T. M.
- Affiliations
- Institute of Human Genetics (PL)
- Children's Hospital of Philadelphia (US)
- Corresponding author
- Grzywa, Tomasz M.
- Venue
- Clinical Reviews in Allergy & Immunology
- Published
- 2024-04-20
- Volume
- 66
- Issue
- 2
- Pages
- 164-191
- ISSN
- 1080-0549 (ISSN-L)
- 1559-0267
- PMC
- PMC11193704
- OpenAlex
- W4394989398
- Semantic Scholar
- 7834ce05fae760dae63e391276786d133a044e08
- Cited by
- 346
- References
- 308
- Citations by year
- 2026: 187 · 2025: 140 · 2024: 19
- FWCI
- 15.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Clinical Reviews in Allergy & Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Narodowe Centrum Nauki (2021/41/N/NZ6/02774)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Rheumatology › Spondyloarthritis Studies and Treatments
- Keywords
- psoriasis, psoriasis pathogenesis, dendritic cells, Th17 cells, keratinocytes, IL-23, TNF-α, IL-17, IL-22, Th9 cells, Th22 cells, cytotoxic T lymphocytes, neutrophils, γδ T cells, innate lymphoid cells, mast cells, non-immune cells, skin inflammation, immune dysregulation
- MeSH terms
- Animals, Dendritic Cells, Humans, Psoriasis, Skin, Signal Transduction, Keratinocytes, T-Lymphocyte Subsets, Cytokines, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.